SecBot SecBot
425 ·Filed Jun 10, 2026

PCSC

Perceptive Capital Solutions Corp
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001140361-26-024796
Rule 425 M&A communications
Actionable Insight • Neutral

The extension removes near-term liquidation risk but redemptions reduce deal firepower. Monitor for S-4 effectiveness and definitive proxy mailing in coming weeks; further redemption spikes could pressure deal viability.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
PCSC ▼ -3.28% at T+20d
NEUTRAL call -3.28% · α vs SPY -5.17% · entry $11.27 → $10.90
Next anchor: T+60d due 8w ago
Entry = T+0 close
Jun 10, 2026
via day close
T+1d
+1.15%
call +1.15% · α +0.61%
$11.40
settled 5mo ago
T+5d
-0.98%
call -0.98% · α -1.41%
$11.16
settled 4mo ago
T+20d
-3.28%
call -3.28% · α -5.17%
$10.90
settled 4mo ago
T+60d
Pending
due 8w ago

Price Chart

Loading chart...

Executive Summary

PCSC shareholders approved a one-year extension of the deadline to consummate a business combination to June 13, 2027, while 754,008 shares were redeemed for $8.16 million, leaving $85.17 million in trust. The filing keeps the pending Freenome deal on track but signals moderate shareholder redemption pressure.

Key Facts

  • Shareholders approved extension of business combination deadline from June 13, 2026 to June 13, 2027.
  • 754,008 Class A shares redeemed at ~$10.82 per share for total $8.16 million.
  • Trust account balance after redemptions: approximately $85.17 million.
  • Business combination with Freenome Holdings remains pending; S-4 registration statement filed.

Financial Impact

Trust account reduced by $8.16 million (8.7% of prior balance) due to shareholder redemptions; remaining $85.17 million available for the Freenome deal.

trust account balancecash available for business combination

Risk Factors

  • Additional shareholder redemptions if deal terms are unfavorable or delay continues.
  • Failure to close Freenome business combination by new June 2027 deadline.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001140361-26-024796
Document: ef20075826_ex3-1.htm0001140361-26-024796
Document: 0001140361-26-024796-index-headers.html0001140361-26-024796
Document: 0001140361-26-024796-index.html0001140361-26-024796
Document: 0001140361-26-024796.txt0001140361-26-024796
12 reports for PCSC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PCSC — sortable, filterable
TypeNow
Jul 22, 2026
13w ago
3
NEUTRAL ★ 3/10
$12.01awaiting T+5——
Jul 22, 2026
13w ago
3
NEUTRAL ★ 3/10
$12.01awaiting T+5——
Jul 20, 2026
14w ago
25-NSE
BEARISH ★ 9/10
$12.01awaiting T+5——
Jul 9, 2026
15w ago
425
BULLISH ★ 7/10
$10.90 $12.00▲ +10.09%▲ +10.22%—
Jul 9, 2026
15w ago
425 / 8-K
NEUTRAL ★ 4/10
$10.90 $12.00▲ +10.09%▲ +10.22%—
Jun 18, 2026
18w ago
425
NEUTRAL ★ 4/10
$11.01 $10.93▼ −0.73%▲ +1.34%—
Jun 18, 2026
18w ago
8-K
NEUTRAL ★ 5/10
$11.01 $10.93▼ −0.73%▲ +1.34%—
Jun 18, 2026
18w ago
EFFECT
NEUTRAL ★ 5/10
$11.09 $10.96▼ −1.17%▲ +0.49%—
Jun 11, 2026
19w ago
S-4/A
NEUTRAL ★ 4/10
$11.40 $11.09▼ −2.72%▼ −3.39%—
Jun 10, 2026
19w ago
425
NEUTRAL ★ 4/10
$11.27 $11.16▼ −0.98%▼ −1.41%—
Showing 10 of 12

US Market Status

Market Closed — Opens Thu (10h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026